Muscle-resident FAPs also increase and accumulate in a muscle fibrosis model of chronic kidney disease (Dong et al., 2017) and chronic kidney disease human patients (Abramowitz et al., 2018), and are accompanied by enhanced muscle atrophy and FAP-mediated adipogenesis (Hu et al., 2019). The gene discussed is FAP; the disease is chronic kidney disease.